Yasu Jiang

613 total citations
19 papers, 485 citations indexed

About

Yasu Jiang is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yasu Jiang has authored 19 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Yasu Jiang's work include RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (6 papers). Yasu Jiang is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (6 papers). Yasu Jiang collaborates with scholars based in China. Yasu Jiang's co-authors include Feiran Wang, Weiwei Shao, Dong Xu, Junfei Xu, Xianchen Liu, Xi Wang, Ying Liu, Jun Qin, Haiyan Jiang and Zhiwei Wang and has published in prestigious journals such as Cell Cycle, Journal of Cellular and Molecular Medicine and Diabetes Research and Clinical Practice.

In The Last Decade

Yasu Jiang

18 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasu Jiang China 13 410 279 46 37 26 19 485
Jun-Shuang Jia China 13 253 0.6× 170 0.6× 39 0.8× 22 0.6× 34 1.3× 22 387
Zhonghai Guan China 8 280 0.7× 189 0.7× 78 1.7× 41 1.1× 43 1.7× 18 370
Liangliang Dong China 11 305 0.7× 216 0.8× 35 0.8× 97 2.6× 23 0.9× 25 420
Brian McCue United States 5 389 0.9× 340 1.2× 37 0.8× 25 0.7× 18 0.7× 8 472
Mingchen Zhu China 11 374 0.9× 262 0.9× 76 1.7× 23 0.6× 58 2.2× 26 496
Xiao Albert Zhou China 8 366 0.9× 242 0.9× 82 1.8× 16 0.4× 59 2.3× 14 512
Yuchun Niu China 8 454 1.1× 375 1.3× 107 2.3× 44 1.2× 23 0.9× 14 533
Can Yang China 9 229 0.6× 129 0.5× 62 1.3× 34 0.9× 49 1.9× 17 329
Yudong Zhang China 9 457 1.1× 221 0.8× 84 1.8× 35 0.9× 55 2.1× 12 524

Countries citing papers authored by Yasu Jiang

Since Specialization
Citations

This map shows the geographic impact of Yasu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasu Jiang more than expected).

Fields of papers citing papers by Yasu Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasu Jiang. The network helps show where Yasu Jiang may publish in the future.

Co-authorship network of co-authors of Yasu Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yasu Jiang. A scholar is included among the top collaborators of Yasu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasu Jiang. Yasu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jiang, Yasu, Peng Chen, Chengwei Duan, et al.. (2024). Correlational analysis of PLIN1 with inflammation in diabetic foot ulcer wounds. Diabetes Research and Clinical Practice. 209. 111605–111605. 2 indexed citations
2.
Jiang, Yasu, et al.. (2022). Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer. Journal of Gastrointestinal Oncology. 13(5). 2234–2248. 4 indexed citations
3.
Zhang, Yi, et al.. (2022). LncRNA NEAT1 Targets miR-342-3p/CUL4B to Inhibit the Proliferation of Cutaneous Squamous Cell Carcinoma Cells. Journal of Oncology. 2022. 1–8. 3 indexed citations
4.
Wan, Ying, et al.. (2021). CAP2 contributes to tumorigenesis in gastric cancer by targeting transcription factor SOX9. Journal of Gastrointestinal Oncology. 12(2). 268–277.
5.
Wu, Yu, et al.. (2021). Application of nanocarbon negative imaging technology in surgery for secondary hyperparathyroidism. Gland Surgery. 10(8). 2455–2461. 3 indexed citations
6.
Ji, Jiang, Jian Yao, Jianfeng Ji, et al.. (2021). SphK1-targeted miR-6784 inhibits functions of skin squamous cell carcinoma cells. Aging. 13(3). 3726–3741. 5 indexed citations
7.
Wang, Feiran, et al.. (2020). Identifying the hub gene in gastric cancer by bioinformatics analysis and in vitro experiments. Cell Cycle. 19(11). 1326–1337. 20 indexed citations
8.
Wang, Feiran, Dong Xu, Yijie Tang, et al.. (2020). LncRNA ADAMTS9‐AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating SPOP. Journal of Cellular and Molecular Medicine. 24(8). 4830–4838. 21 indexed citations
9.
Zhou, Feng, et al.. (2019). miRNA-221 promotes cutaneous squamous cell carcinoma progression by targeting PTEN. Cellular & Molecular Biology Letters. 24(1). 9–9. 43 indexed citations
10.
Jiang, Yasu, et al.. (2019). MicroRNA‑144 suppresses aggressive phenotypes of tumor cells by targeting ANO1 in colorectal cancer. Oncology Reports. 41(4). 2361–2370. 28 indexed citations
11.
Xu, Dong, Weiwei Shao, Yasu Jiang, et al.. (2017). FTO expression is associated with the occurrence of gastric cancer and prognosis. Oncology Reports. 38(4). 2285–2292. 137 indexed citations
12.
Jiang, Yasu, et al.. (2017). miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin. Oncology Letters. 13(3). 1319–1324. 15 indexed citations
13.
Jin, Ke, Weiwei Shao, Yasu Jiang, et al.. (2017). MicroRNA‑103 regulates tumorigenesis in colorectal cancer by targeting ZO‑1. Molecular Medicine Reports. 17(1). 783–788. 14 indexed citations
14.
Wang, Feiran, Yong Qiang, Yasu Jiang, et al.. (2016). MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis. Tumor Biology. 37(8). 10235–10246. 40 indexed citations
15.
Xu, Junfei, et al.. (2016). Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer. OncoTargets and Therapy. 9. 477–477. 13 indexed citations
16.
Jiang, Yasu, Weiwei Shao, Wen Shi, et al.. (2016). Abnormal expression of FOSB correlates with tumor progression and poor survival in patients with gastric cancer. International Journal of Oncology. 49(4). 1489–1496. 26 indexed citations
17.
Xu, Junfei, Feiran Wang, Haiyan Jiang, et al.. (2015). Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer. Journal of Gastrointestinal Surgery. 19(8). 1484–1496. 27 indexed citations
18.
Wang, Zhiwei, Jun Qin, Jing Ke, et al.. (2015). Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer. OncoTargets and Therapy. 8. 3639–3639. 36 indexed citations
19.
Qin, Jun, Feiran Wang, Haiyan Jiang, et al.. (2015). MicroRNA-145 suppresses cell migration and invasion by targeting paxillin in human colorectal cancer cells.. PubMed. 8(2). 1328–40. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026